Baseline characteristics, parameters of FGF23-Klotho-1,25(OH)2D3 axis, and cardiovascular measures in GH-treated pediatric patients with CKD stages 3–5 and matched controls. The gene discussed is GH1; the disease is chronic kidney disease.